Core Laboratories Inc. CLB
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.38M | 22.74M | 22.82M | 22.70M | 25.63M |
| Total Receivables | 127.01M | 116.08M | 115.19M | 120.80M | 124.97M |
| Inventory | 60.70M | 57.96M | 57.78M | 54.50M | 58.24M |
| Prepaid Expenses | 10.21M | 10.95M | 11.36M | 9.73M | 10.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.76M | 6.63M | 7.22M | 6.94M | 8.01M |
| Total Current Assets | 225.06M | 214.36M | 214.37M | 214.67M | 226.91M |
|
|
|||||
| Total Current Assets | 225.06M | 214.36M | 214.37M | 214.67M | 226.91M |
| Net Property, Plant & Equipment | 151.99M | 153.26M | 154.69M | 153.79M | 152.01M |
| Long-term Investments | 105.92M | 105.80M | 105.80M | 105.79M | 100.01M |
| Goodwill | 105.92M | 105.80M | 105.80M | 105.79M | 100.01M |
| Total Other Intangibles | 6.64M | 6.75M | 6.89M | 7.12M | 6.11M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 103.92M | 106.61M | 105.98M | 98.22M | 106.32M |
| Total Assets | 593.52M | 586.78M | 587.73M | 584.01M | 591.36M |
|
|
|||||
| Total Accounts Payable | 40.01M | 40.16M | 39.98M | 37.28M | 36.95M |
| Total Accrued Expenses | 24.19M | 25.25M | 26.36M | 30.80M | 27.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.72M | 11.94M | 12.10M | 11.46M | 11.47M |
| Total Finance Division Other Current Liabilities | 26.82M | 23.70M | 26.30M | 26.49M | 20.11M |
| Total Other Current Liabilities | 26.82M | 23.70M | 26.30M | 26.49M | 20.11M |
| Total Current Liabilities | 102.73M | 101.05M | 104.73M | 106.02M | 95.74M |
|
|
|||||
| Total Current Liabilities | 102.73M | 101.05M | 104.73M | 106.02M | 95.74M |
| Long-Term Debt | 112.45M | 113.86M | 114.46M | 110.26M | 114.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 37.81M | 39.31M | 41.29M | 42.31M | 41.53M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 56.44M | 53.78M | 52.11M | 53.22M | 62.60M |
| Total Liabilities | 309.43M | 308.01M | 312.58M | 311.80M | 313.97M |
|
|
|||||
| Common Stock & APIC | 117.12M | 115.98M | 115.69M | 110.72M | 114.34M |
| Retained Earnings | 181.89M | 176.91M | 171.41M | 172.66M | 173.60M |
| Treasury Stock & Other | -21.05M | -20.22M | -18.22M | -17.39M | -16.60M |
| Total Common Equity | 277.97M | 272.67M | 268.89M | 265.99M | 271.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 277.97M | 272.67M | 268.89M | 265.99M | 271.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 6.12M | 6.10M | 6.26M | 6.22M | 6.04M |
| Total Equity | 284.09M | 278.77M | 275.14M | 272.21M | 277.39M |
|
|
|||||